Literature DB >> 25263458

The interplay between cell death signaling pathways in the heart.

Agnieszka K Biala1, Lorrie A Kirshenbaum2.   

Abstract

To date, one of the most intriguing and compelling concepts to impact contemporary cell biology is the notion that cell fate is "programmed" or genetically controlled. Indeed, the regulation of cell fate is crucial for embryonic development, and tissue homeostasis. Given the importance of removing damaged or irreversibly injured cells from the body, it is not surprising that defects in the regulatory mechanisms that govern cell death and/or survival more generally have been implicated in a number of human pathologies including cancer, neurodegenerative diseases, and cardiac failure. Several processes involved in the regulation of cell fate through apoptosis, necrosis, and autophagy are commonly linked through the actions of certain Bcl-2 proteins that act on the mitochondrion. For example, the Bcl-2 protein Beclin-1 is actively involved in the clearance of damaged mitochondria via mitophagy, while other Bcl-2 proteins such as Bax/Bak can initiate apoptosis or necrotic signaling pathways. The overlapping and redundant nature of these proteins highlights their evolutionary importance for regulating cardiac cell survival and death during normal and disease states. Here, we explore the interrelationship between these signaling pathways and the cellular effectors that influence cardiac cell fate.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25263458     DOI: 10.1016/j.tcm.2014.08.002

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  16 in total

1.  Identification of Functional Genetic Determinants of Cardiac Troponin T and I in a Multiethnic Population and Causal Associations With Atrial Fibrillation.

Authors:  Yunju Yang; Traci M Bartz; Michael R Brown; Xiuqing Guo; Nuno R Zilhão; Stella Trompet; Stefan Weiss; Jie Yao; Jennifer A Brody; Christopher R Defilippi; Ron C Hoogeveen; Henry J Lin; Vilmundur Gudnason; Christie M Ballantyne; Marcus Dörr; J Wouter Jukema; Astrid Petersmann; Bruce M Psaty; Jerome I Rotter; Eric Boerwinkle; Myriam Fornage; Goo Jun; Bing Yu
Journal:  Circ Genom Precis Med       Date:  2021-11-04

Review 2.  Targeting mitochondrial dysfunction with elamipretide.

Authors:  Chukwuemeka Obi; Alexander T Smith; Gregory J Hughes; Adedayo A Adeboye
Journal:  Heart Fail Rev       Date:  2022-01-17       Impact factor: 4.654

Review 3.  Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.

Authors:  Geoffrey W Cho; Francisco Altamirano; Joseph A Hill
Journal:  Biochim Biophys Acta       Date:  2016-01-13

Review 4.  Mitochondrial involvement in myocyte death and heart failure.

Authors:  Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

5.  Ulk1/Rab9-mediated alternative mitophagy confers cardioprotection during energy stress.

Authors:  Rimpy Dhingra; Inna Rabinovich-Nikitin; Lorrie A Kirshenbaum
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

6.  YAP/TFEB pathway promotes autophagic cell death and hypertrophic cardiomyopathy in lysosomal storage diseases.

Authors:  Inna Rabinovich-Nikitin; Lorrie A Kirshenbaum
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 7.  A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.

Authors:  Leonardo Schirone; Maurizio Forte; Silvia Palmerio; Derek Yee; Cristina Nocella; Francesco Angelini; Francesca Pagano; Sonia Schiavon; Antonella Bordin; Albino Carrizzo; Carmine Vecchione; Valentina Valenti; Isotta Chimenti; Elena De Falco; Sebastiano Sciarretta; Giacomo Frati
Journal:  Oxid Med Cell Longev       Date:  2017-07-02       Impact factor: 6.543

Review 8.  Crosstalk between Autophagy and Apoptosis: Potential and Emerging Therapeutic Targets for Cardiac Diseases.

Authors:  Meng Li; Ping Gao; Junping Zhang
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

9.  Inhibition of miR-29c promotes proliferation, and inhibits apoptosis and differentiation in P19 embryonic carcinoma cells.

Authors:  Bin Chen; Guixian Song; Ming Liu; Lingmei Qian; Lihua Wang; Haitao Gu; Yahui Shen
Journal:  Mol Med Rep       Date:  2016-01-29       Impact factor: 2.952

10.  Overexpression of miR-1298 attenuates myocardial ischemia-reperfusion injury by targeting PP2A.

Authors:  Chun Ouyang; Lei Huang; Xiaoqiang Ye; Mingming Ren; Zhen Han
Journal:  J Thromb Thrombolysis       Date:  2021-08-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.